S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200001 Bases moleculares del reconocimiento de los antígenos Lomonte Bruno ,Universidad de Costa Rica Facultad de Microbiología 04 1999 1999 13 52 54 Abbas AK Lichtman AH Pober JS Cellular and Molecular lmmunology Cellular and Molecular lmmunology 1994 Philadelphia W.B. Saunders Company Calderón L. Lomonte B Inhibition of the myotoxic action of Bothrops asper myotoxin II in mice by immunization with its synthetic peptide 115-129 Toxicon 1999 37 Davis MM Chien Y lssues concerning the nature of antigen recognition by <IMG SRC="cuadrito.JPG" WIDTH=9 HEIGHT=10><IMG SRC="cuadrito.JPG" WIDTH=9 HEIGHT=10> and <IMG SRC="cuadrito.JPG" WIDTH=9 HEIGHT=10><IMG SRC="cuadrito.JPG" WIDTH=9 HEIGHT=10> T-cell receptors Immunol. Today 1995 16 Greenspan N Cooper L Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions lmmunol. Today 1995 16 Janeway CA Travers P lmmunobiology: the lmmune System in Health and Disease lmmunobiology: the lmmune System in Health and Disease 1996 ^eNew York Garland Publishing lnc. Kuby J lmmunology lmmunology 1997 ^eNew York W.H. Freeman and Company Lechler R Pla M The credentials of a T-cell epitope lmmunol. Today 1995 16 Lomonte B Nociones de lnmunología Nociones de lnmunología 1998 ^eSan José Editorial Lara, Segura & Asociados Van Regenmortel M.H.V Synthetic Peptides as Antigens Synthetic Peptides as Antigens 1988 Elsevier^eAmsterdam Van Regenmortel MHV Synthetic peptides help in diagnosing viral infections ASM News 1998 64

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200002 Métodos moleculares para el desarrollo de vacunas García Fernando ,Universidad de Costa Rica Facultad de Microbiología Centro de Investigación en Enfermedades Tropicales 04 1999 1999 13 55 59 Butterton JR Beattie DT Gardel CL Heterologous antigen expression in Vibrio cholerae vector strains lnfect. lmmun. 1995 63 Buynak EB Hilleman MR Live attenuated mumps virus vaccine: I. Vaccine development Proc. Soc. Exp. Biol. Med. 1966 123 Clark HF Borian FE Bell LM Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantiy serotype 1 rotavirus season J. lnfect. Dis. 1988 158 Clark HF Offit PA Ellis RW The development of multivalent bovine rotavirus (strain CW3) reassortant vaccine for infants J. lnfect. Dis. 1996 174 Clemens JD Sack DA Harris JR Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up Lancet 1990 355 Crawford CR Faiza AM Mukhlis FA Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1 . Preparation and characterization of disrupted virions Vaccine 1984 2 Chatfield SN Fairweather NF Charles IG Pickard D Levine MM Hone D Posada M Strugnell RA Dougan G Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine Vaccine 1992 10 Chazono M Yoshida I Konobe T The purification and characterization of an acellular pertussis vaccine J. Biol. Stand. 1988 16 Cherry JD Brunell PA Golden GS Karzon DT Report of the task force on pertussis and pertussis immunization - 1988 Pediatrics 1988 81 Enders JF Katz SL Milovanovi MV Holloway A Studies on an attenuated measles-virus vaccine: I. Development and preparation of the vaccine: technics for assay of effects of vaccination N. Engl. J. Med. 1960 263 Fries LF Tartaglia J Taylor J Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternativa poxvirus vector system Vaccine 1996 14 Germanier R Furer E lsolation and characterization of ga/E mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine J. lnfect. Dis. 1975 131 Ghendon YZ Klimov Al Alexandrova GI Polezhaev Fl Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains J. Gen. Virol. 1981 53 Giannini G Rappuoli R Ratti G The amino-acid sequence of two non-toxic mutants of diphteria toxin: CRM45 and CRM197 Nucleic Acid Res. 1984 12 Goosens PL Montixi C Saron MF Listeria monocytogenes: a live vector able to deliver heterologous proteins within the cytosol and to drive a CD8-dependent T-cell response Biologicals 1995 23 Gotschlich EC Liu TY Artenstein MS Human immunity to the meningococcus. III: Preparation and immunochemical properties of the group A, group B and group C meningococcal polysaccharides J. Exp. Med 1969 129 Guérin C Rosenthal SR The history of BCG BCG vaccination against tuberculosis BCG vaccination against tuberculosis 1957 Boston Little, Brown & Co Henderson DA Smallpox eradication Proc. R. Soc. Lond. 1977 199 Hilleman MR Bertlan AU Buynak EB Vyas GN Cohen SN Schmid R Clinical and laboratory studies of HbsAg vaccine Viral hepatitis Viral hepatitis 1978 Philadelphia Franklin Instituto Press Jones FG Moss JM Studies on tetanus toxoid: I. The antitoxic titer of human subject following immunization with tetanus toxoid and tetanus alum precipitated toxoid J. lmmunol. 1936 30 Kass EG Assessment of the pneumococcal polysaccharide vaccine Rev. lnfect. Dis. 1981 3 Kent SJ Stallard V Corey L Analysis of cytotoxic lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vacinia and fowlpox viruses AIDS Res. Hum. Retroviruses 1994 10 Klein D Ellis RW Levine MM Woodrow GC Kaper JB Cobon GS Pneumococcal conjugase vaccines New generation vaccines New generation vaccines 1997 ^eNew York Marcel Dekker Knistern PJ Marburg S Ellis RW Powell M Newman M Haemophilus influenzae type b conjugase vaccines Vaccine design: the subunit approach Vaccine design: the subunit approach 1995 ^eNew York Plenum Publishing Krieg AM Yi AK Matson S CpG motifs in bacterial DNA trigger direct B-cell activation Nature 1995 374 Maassab HF DeBorde DC Development and characterization of cold-adapted viruses for use as live virus vaccines Vaccine 1985 3 McKay E Higgins P Tyrrel D Pringle C lmmunogenicity and pathogenicity of temperature sensitive modified respiratory syncytial virus in adult volunteers J. Med. Virol. 1988 25 Murdin AD Barreto L Plotkin S lnactivated polio vaccines: past and present experience Vaccine 1996 14 Noriega FR Losonsky G Wang JY Further characterization of <IMG SRC="triangulo.JPG" WIDTH=11 HEIGHT=15>aroA <IMG SRC="triangulo.JPG" WIDTH=11 HEIGHT=15>virG Shigella flexneri as a mucosal Shigella vaccine and a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli lnfect. lmmun. 1996 64 Perales MA Schwartz DH Fabry JA Lieberman J A vaccinia-gp160-based vaccine but not a gp160 vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees J. Acquir. lmmune Defic. Syndr. Hum. Retrovirol. 1995 10 Plotkin SA Farquhar JD Katz M Buser F Attenuation of RA27/3 rubella virus in WI-38 human diploid cells Am. J. Dis. Child. 1969 118 Plotkin SA Rabies vaccine prepared in human cell cultures: progress and perspectivas Rev. Infect. Dis. 1980 2 Provost PJ Hughes JV Miller WJ An inactivated hepatitis A viral vaccine of cell culture origin J. Med. Virol. 1986 19 Ramon G Sur le pouvoir floculant et sur les proprietes immunisantes d'une toxin diphterique rendue anatoxique (anatoxine) C. R. Acad. Sci. 1923 177 Remy JS Sirlin C Vierling P Behr JP Gene transfer with a series of lipophilic DNA-binding molecules Bioconjug. Chem 1994 5 Rennels MB Glass RI Dennehy PH Safety and efficacy of high-dose Rhesus-human reassortant rotavirus vaccines - report of the national multicenter analysis Pediatrics 1996 97 Rodrigues LP Schneerson R Robbins JB lmmunity to H. influenzae type b I. The isolation and some physicochemical, serologic and biologic properties of the capsular polusaccharide of H. influenzae type b J. Immunol 1971 107 Sabin AB Boulger LR History of Sabin attenuated poliovirus vaccine J. Biol. Stand. 1973 1 Sizemore DR Branstrom AA Sadoff JC Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization Science 1996 270 Stover CK de la Cruz VF Fuerst TR Burlein JE Benson LA Bennett LT Bansal GP Young JF Lee MH Hatfull GF Snapper SB Barletta RG Jacobs WR, Jr Bloom BR New use of BCG for recombinant vaccine Nature 1991 351 Svennerholm AM Holmgren J Sack DA Development of oral vaccines against enterotoxigenic Escherichia coli diarrhoea Vaccine 1989 7 Takahashi M Okuno Y Otsuka T Development of a live attenuated varicella vaccine Biken J 1975 18 Wolff JA Malone RW Williams P Chong W Ascadi G Jani A Felgner PL Direct gene transfer into mouse muscle in vivo Science 1990 247

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200003 Poliomielitis: estrategias vacunales Somogyi Teresita ,Universidad de Costa Rica Facultad de Microbiología 04 1999 1999 13 60 63 Abraham R Minor P Dunn G Modlin JF Ogra PL Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccines after prior immunization with inactivated polio vaccine J. lnfect. Dis. 1993 168 Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine-recommendations of the Advisory Committee on lmmunization Practices MMWR 1997 46 Certification of poliomyelitis eradication-the Americas MMWR 1994 43 Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine Morbid. Mortal. Weekly Rep 1997 46 Chen RT Hausinger S Dajani A Seroprevalence of antibody against poliovirus in inner-city preschool children: implications for vaccination policy in the United States JAMA 1996 275 Poliomyelitis prevention: Recommendations for use of inactivated poliovirus and live oral poliovirus vaccine Pediatrics 1997 99 Faden H Modlin JF Thoms ML McBean A Ferdon MB Ogra PL Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responsos J. lnfect. Dis 1990 162 Faden H Duffy L Sun M Shuff C Long-term immunity to poliovirus in children immunized with live attenuated an enhanced-potency inactivated trivalent poliovirus vaccine J. Infect. Dis. 1993 168 Lutwick L Warts on the poliosaur bones: the successes and failures of poliomyelitis vaccines in the U.S Infect. Med. 1997 14 ^s6 Kelly PW Petruccelli BP Stehr-Green P Erickson RL Mason CJ The susceptibility of young adult Americans to vaccines preventable infections: a national serosurvey of US army recruits JAMA 1991 266 McBean AM Modlin JF Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine immunization in the United States Pediatr. lnfect. Dis. J. 1987 6 Mensi C Pregliasco F Poliomyelitis: present epidemiological situation and vaccination problems Clin. Diag. Lab. lmmunol. 1998 5 ^s3 Melnick JL Current status of poliovirus infections 1996 9 ^s3 Miller MA Sutter RW Strebel PM Hadler SC Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule JAMA 1996 276 Modlin JF Halsey NA Thoms ML Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccines - live attenuated poliovirus vaccines immunization schedules J. Infect. Dis. 1997 175 ^ssuppl 1 Ogra PL Faden HS Abraham R Duffy LC Sun M Minor PD Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines J. lnfect. Dis. 1991 164 Onorato l.M. Modlin J.F. McBean A.M. Thomas M.L Losonsky G.A. Bernier R.H. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines J. Infect. Dis. 1991 163 Oostvogel PM van Wijngaarden JK vaan der Avoort HGAM Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-1993 Lancet 1994 344 Plotkin S Murdin A Vidor E Plotkin S Orenstein W lnactivated polio vaccine Vaccines Vaccines 1999 3rd Edition W.B. Saunders Company Simoes EA Hoeprich PD Jordan MC Ronald A Poliomyelitis infectious Diseases infectious Diseases 1999 5th Edition J.B. Lippincott Company Strebel PM Sutter RW Cochi SL Epidemiology of poliomyelitis in the United States one decade after the last reportes case of indigenous wild virus-associated disease Clin. Infect. Dis. 1992 14 Sutter R Cochi SL Melnick J Plotkin S. Orenstein W. Live attenuated poliovirus vaccines Vaccines Vaccines 1999 3rd Edition W.B. Saunders Company Williams AL News and perpectives: New vaccines for childhood immunization Drug Benefit Trends 1997 9

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200004 Vacuna difteria, tosferina y tétanos Abdelnour Arturo ,CCSS Hospital Nacional de Niños 04 1999 1999 13 64 64 Pertussis surveillance-United States, 1989-1991 MMWR 1992 41 ^sSS-8 Cherry JD "Pertussis vaccine encefalopathy". It is time to recognize it as the myth that it is JAMA 1990 263 Cody CL Baraff LJ Cherry JD Nature and rates of adversa reactions associated with DTP and DT inminuzations in infants and children Pediatrics 1981 68 Edwards KM Decker MD Acellular pertussis vaccines for infants N Engl J Med 1996 334 Hodder SL Mortimer EA Jr Epidemiology of pertussis and reactions to pertussis vaccine Epidemiol Rev 1992 14 Lang JP Mink CA The effectiveness of acellular and whole-cell pertussis vaccines lnfect Med 1995 12 Walker AM Jick H Perera DR Knauss TA Thompson RS Neurologic events following difteriatetanus-pertussis Pediatrics 1988 81

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200005 Vacunas para cólera y fiebre tifoidea Herrera Hidalgo Marco Luis ,CCSS Hospital Nacional de Niños 04 1999 1999 13 65 67 Benenson A Joseph P Oseasohn R Cholera vaccine field trials in East Pakistan Bull World Health Organ 1968 38 Blake P Epidemiology of cholera in the Americas Gastroenterol Clin North Am 1993 22 Clemens J Jertborn M Sack D Effect of neutralization of gastric acid on inmune responses to an oral B sununited, killed whole cell cholera vaccines J. Infect Dis 1986 154 Glass R Svernnerholm A Stoll B Protection against cholera in breast-fed children by antibodies in breast milk N. Engl. J. Med. 1983 308 Keitel W Bon N Zahradnik J Clinical and serological responses following primary and booster With Salmonella typhi Vi capsular polysaccharide vaccines Vaccine 1994 12 Kantelle A Arvilommi H Kantelle J Comparison of the human immune response to oral live, Killed oral or killed parenteral Salmonella typhi Ty21a vaccines Microb Pathog. 1991 10 Levine MM Vaccines and milk inmunoglobulin concentrases for prevention of infectious diarrhea J. Pediatric 1983 118 Levine M Kaper J Herrington D Safety, immunogenicity and efficacy of recombinant live oral cholera vaccines, CDV 103 and CVD 103-HgR Lancet 1988 2 Levine MM Plotkin S. Orestein W. Typhoid Fever Vaccines Vaccines Vaccines 1999 3ª ed W.B. Saunders Company Sack D Cadoz M Plotkin S. Orestein W Cholerae Vaccines Vaccines Vaccines 1999 3ª ed W.B. Saunders Company Svennerholm AM Jertborn M Gothefors L Mucosal antitoxic and antibacterial inmunity after cholera diseases and after immunization with comined B subunited-whole cell vaccines J. Infec Dis. 1984 149 Tacket C Ferreccio C Robbins J Safety and inmunogenicity of Salmonella thypi Vi capsular polysacchride vaccines International List of Availability of Vaccines International List of Availability of Vaccines 1995 Geneve

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200006 Vacunas para Citomegalovirus Alfaro-Bourrouet Wilbert ,CCSS Hospital Nacional de Niños San José Costa Rica 04 1999 1999 13 68 70 Adler S Starr S Plotkin S Hempfing S Buis J Manning M Best A lmmunity induced by primary human Cytomegalovirus infection against secondary infection among women of childbearing age J lnfect Dis 1995 171 Adler S Hempfling S Starr S Plotkin S Riddell S Safety and immunogenicity of the Towne strain cytomegalovirus vaccine Pediatr Infect Dis J 1998 17 Britt W Fay J Seals J Kensil C Formulation of an immunogenic human Cytomegalovirus vaccine: Response in mice J lnfect Dis 1995 171 Chou S Dennison K Analysis of interstrain variation in Cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes J lnfect Dis 1991 163 Elek SD Stern H Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero Lancet 1974 1 Gönczöl E lanacone J Furlini G Ho W Plotkin S Humoral immune response to Cytomegalovirus Towne vaccine strain and to Toledo low-passage strain J lnfect Dis 1989 159 ^s5 Porath A McNutt R Smiley L Weigle K Cost benefit of a proposed live Cytomegalovirus vaccine in the prevention of congenital disease Rev lnfect Dis 1990 12 ^s1 Plotkin S Starr S Friedman H Gönczöl E Weibel R Protective effects of Towne Cytomegalovirus vaccine against low-passage Cytomegalovirus administered as a challenge J lnfect Dis 1989 159 ^s5 Plotkin S Starr S Friedman H Gönczöl E Brayman K Vaccines for the prevention of human Cytomegalovirus infection Rev lnfect Dis 1990 12 ^sS7 Plotkin S Higgins R Kurtz J Morris P Campbell D Shope T Spector S Dankner W Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients Transplantation 1994 58 Plotkin S Plotkin S Orenstein W Cytomegalovirus vaccines Vaccines Vaccines 1999 W.B Saunders Harrison C Britt W Chapman N Mullican J Tracy S Reduced congenital Cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestional primary CMV infection in the guinea pig model J Infect Dis 1995 172 Marshall G Ricciardi R Rando R Puck J Ge R Plotkin S Gönczöl E An Adenovirus recombinant that express the human Cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies J lnfect Dis 1990 162 Wang J Adler S Hempfling S Burke R Duliège A Starr S Plotkin S Mucosal antibodies to human Cytomegalovirus glycoprotein B occur following both natural infection and immunization with human Cytomegalovirus vaccines J Infect Dis 1996 174

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200007 Vacuna contra el virus de la influenza Herrero Uribe Libia ,Universidad de Costa Rica Facultad de Microbiología 04 1999 1999 13 68 70 Webster RG Morse S.S. Influenza Emerging Viruses Emerging Viruses 1993 ^eNew York Oxford University Press Murphy BR Webster RG Fields BN Knipe DM Howley PM Orthomyxovirus Virology Virology 1996 Philadelphia Lippincott-Raven Publishers Webster RG Evolution and ecology of influenza A viruses Microbiol Rev 1992 56 Webster RG Palese P Kingsbury DW Antigenic variation among type A influenza viruses Genetics of Influenza Viruses Genetics of Influenza Viruses 1983 ^eVienna Springer-Verlag Easterday BC Kilbourne ED Animal Influenza The influenza viruses and Influenza The influenza viruses and Influenza 1975 Orlando Academic Press Myxovirus Myxovirus 1999 Influenza Vaccine lnformation Influenza Vaccine lnformation 1999 Maassab HF Plotkin Stanley A. Orenstein Walter A. Live Influenza Virus Vaccine Vaccines Vaccines 1999

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200008 Vacunas contra el Virus de la lnmunodeficiencia Humana (VIH) Frajman Mauricio ,CCSS Hospital San Juan de Dios 04 1999 1999 13 73 74 Barre-Sinoussi F Cherman JC Rey F lsolation of a T-Iymphotropic retrovirus from a patient at risk for AIDS Science 1983 220 Colebunders R.L. Latif R.S. Natural history and clinical presentation of HIV-1 AIDS 1991 5 Frajman M SIDA mitos y realidades SIDA mitos y realidades 1990 Edit. Euroamericana Frajman M Aspectos sociales del SIDA Cien Soc 1992 58 Frajman M Perspectivas para una vacuna para SIDA Perspectivas para una vacuna para SIDA 1999 Girard M.P. Excler J.L. Selected Vaccines of the Future: Human Immunodeficiency Virus Selected Vaccines of the Future: Human Immunodeficiency Virus 1999 LaCasse RA Follis KE Trahey M Fusion competent vaccines: broad neutralization of primary isolates of HIV Science 1999 283 ^s5400 Lane HC Masur H Gelmann EP Correlation between immunologic function and clinical subpopulation of patients with AIDS Am J Ed 1985 22 Letvia NL Progress in the development of an HIV-1 vaccine Science 1998 280 Mackewicz CE Blackbourn DJ Levy JA CD8+ T celis suppress HIV replication by inhibiting viral transcription Proc Natl Acad Sci USA 1995 92 Masur H Michelis MA Greene JB An outbreak of community acquired Pneumocistis carinii pneumonia. lnitial manifestation of cellular immune dysfunction N Engl J Med 1981 305 Mullins JI Frenkel LM Reporte del simposio sobre SIDA en Keystone Reporte del simposio sobre SIDA en Keystone ener o 19 Pali WE Can immune response control HIV infection? Cell 1995 82 Van Cott TC Mascola JR. Kaminsky RL. Antibodies with specificity for native gp120 and neutralization activity against primary HIV-1 isolates elicited with oligomeric gp160 J Virol 1997 71 Global estimates of AIDS Global estimates of AIDS Dec 19 98 Geneve OMS

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200009 Vacunas contra Hepatitis A y B Taylor Lissette ,Inciensa Costa Rica 04 1999 1999 13 75 77 Taylor L. Hepatitis NoA NoB Hepatitis NoA NoB 1989 Villarejos V Viral Hepatitis and AIDS Viral Hepatitis and AIDS LSU-International Symposium on Viral Hepatitis and AIDS Diciembre 1986 San José San José Visona K Eduarte CE Zamora E Salazar LM Estudio Epidemiológico de las Hepatitis Virales en San Ramón y Palmares Acta Medica Costarricense 1989 33 Prevention of Hepatitis A Through Active or Passive lmmunization MMWR 1996 45 ^sRR-15 Raymond SK Hepatitis A. Seminar The Lancet 1998 Maynard JE Hepatitis B: Global lmportance and need for control Vaccine 1990 8 Mei-Hwei Chang Universal B vaccination in Taiwan and the lncidence of Hepatocellular carcinoma in children N. Engl. J. Med. 1997 336 Beasley RP Hepatitis B virus: The major etiology of hepatocelular carcinoma Cancer 1988 61 Blumberg BS Sutnick Al London WT Millman L The discovery of Australia antigen and its relation to viral hepatitis Perspect. Virol. 1971 7 Walters GL Kwifpers PC Shunrs AHWM Enzime linked inmunosorbent as for hepatitis B surface antigen J. Infect. Dis. 1977 136 Hollinger FB Vyas GN Dienstag J Hoofnagle JH Prevention of post transfusion hepatitis Viral hepatitis and liver disease Viral hepatitis and liver disease 1984 Orlando Grune & Stratton Zuckerman A Viral hepatitis Transf. Med. 1993 3 Rodríguez A Vargas F Moreno I Hepatitis B en Perez Zeledón Rev. Med. 1989 506 Atkinson W. Furphy L. Humiston SG Pollard B. Nelson R Wolfe C Hepatitis B Hepatitis B 1997 Atlanta^eGeorgia Deparment of Health and Human Services Herrera G Taylor L Visoná K Respuesta Inmune Humoral Contra la Vacuna del Virus de la Hepatitis B Respuesta Inmune Humoral Contra la Vacuna del Virus de la Hepatitis B VII Congreso Nal. Microbiología, Parasitología y Patología Clínica 14 - 16 Dic. 89 Kane M Global Programe for Control of Hepatitis B Vaccine 1995 13 Taylor L Garcia Z Herrera G Luftig RB Visoná KA Low Response to Hepatitis B Virus Vaccine in Costa Rican Health-Care Workers: Letter to the Editor Hepatology 1998 27 ^s2 Poovorawan Y Theamboonlers A Sanpavat S Pongpunlert W Chumderpadetsuk S Safary A Vandepapelière P Nishioka K Susuki H Mishiro S Oda T. The lmmunogenicity and Reactogenicity of Combined Tetravalent Diphtheria, Tetanus, Pertussis and Hepatitis B Vaccine in lnfants Viral Hepatitis and Liver Disease Viral Hepatitis and Liver Disease 1994 ^eTokyo Eds. Springer-Verlag

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200010 Vacuna contra la malaria: una sinopsis Chinchilla Carmona Misael ,Universidad de Costa Rica Departamento de Parasitología 04 1999 1999 13 78 80 Aidoo M Lalvani A ldentification of conserved antigenic components for a cytotoxic T lymphocyteinducing vaccine against malaria Lancet 1995 345 Alonso PL Dgedge M A new ímpetus for malaria research and control Parasitol Tod. 1999 15 Carter R Malaria transmission-blocking vaccines against sexual and mosquito midgut stages of the parasites: the current state of development Recombinant and Synthetic Vaccines Recombinant and Synthetic Vaccines 1994 Cochrane AH Nussenzweig RS Nardin EH Kreier JP. lmmunization against sporozoites Malaria Malaria 1980 vol. 3 ^eNew York Academic Press, Inc. Coppel RL Cwman AF lmmune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences Nature 1984 310 D'Alessandro U Efficacy trial of malaria vaccine SPf66 in gambian infants Lancet 1995 348 Dayal-Drager R Lambert PH Wernsdorfer W.H. Gregor Plasmodial antigens implicated in stage-specific immune protection Principles and practice of malariology Principles and practice of malariology 1988 Edinburg Churchill Livingstone Del Giudice G Towards a malaria vaccine: what is in sight? Immunol. Clin. 1989 8 Engers HD Godal T Malaria vaccine development current status Parasitol. Tod. 1998 14 Good MF Berzofsky JA Miller LH The T cell response to the malaria circumsporoxoite protein: an immunological approach to vaccine development Ann. Rev. lmmunol. 1988 6 Hagan P Bjorvatn B Jepsen S European malaria vaccine initiative Parasitol.Tod. 1999 15 Jones TR Hoffman SL Malaria vaccine development Clin. Microbiol. Rev. 1994 7 Kemp DJ Coppel RL Anders RF Repetitive proteins and genes of malaria Ann. Rev. Microbiol. 1987 41 McBride J Walliker D Morgan G Antigenic diversity in the human malaria parasite Plasmodium falciparum Science 217254 Mitchell GH Progress toward malaria vaccination Current Opinion Inf. Dis 1990 3 Patarroyo ME A synthetic vaccine protects humans against challenge with asexual blood stages of P. falciparum malaria Nature 1988 332 Schwartz RL lmmune response (Ir) genes of the MHC Adv. lmmunol. 1986 38 Talwar Narosa Edit. New Delhi Target AT Malaria vaccines-now and the future Trans. Roy. Soc.Trop. Med. Hyg. 1995 89 Valero MV Amador LR Vaccination with SPf66, a chemically synthesized vaccine, against Plasmodium falciparum malaria in Colombia Lancet 1993 341 Wahlgren N Anti P. falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity Ann. J. Trop. Med. Hyg. 1986 35 Wang R Charoenvit Y lnduction of protective polyclonal antibodies by inmunization with a P. yoelii circumsporozoite protein multiple antigen peptide vaccine J. lmmunol. 1995 154

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200011 Vacunas contra Meningococo: estado actual y futuras posibilidades Avila María Luisa ,CCSS Hospital Nacional de Niños San José Costa Rica 04 1999 1999 13 81 84 Barnett ED Breña AE McNamara ER Response to quadrivalent meningococcal vaccines in children less than 2 years of age Pediatr Res 1996 ^spt2 Bjune G Hojby EA Gronnesby JK Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Lancet 1991 338 Carlone GM Williams D Dykes J Comparison of serum bactericidal results using vaccine type-strains and heterologous target strains to evaluate immunogenicity of two meningococcal serogroup B vaccines in lceland Comparison of serum bactericidal results using vaccine type-strains and heterologous target strains to evaluate immunogenicity of two meningococcal serogroup B vaccines in lceland 9th Internacional Pathogenic Neisseria Conference 1994 Sep26-30 Winchester Ceesay SJ Allen SJ Menon A Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization J lnfect Dis 1993 167 De Moraes JC Perkins BA Camargo MCC Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil Lancet 1992 340 El Bushra HE Mawlawi MY Fontaine RE Meningococcal meningitis group A: a sucessful control of an outbreak by mass vaccination E Afr Med J 1995 72 Fairley CK Begg N Borrow R Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infant J lnfect Dis 1995 171 Greewood AM Greewood BM Bradley AK Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chioroquine Ann Trop Med Parasitol 1981 75 King J MacDonald N Huang J 3 year follow-up and booster response to quadrivalent meningococcal polysaccharide vaccine Pediatr Res 1996 39 ^spt2 MacDonald N Halperin S Law B lmmunization of toddlers with Chiron conjugated meningococcal C vaccine induces immunologic memory while plain Men polysaccharide vaccine induces tolerance lmmunization of toddlers with Chiron conjugated meningococcal C vaccine induces immunologic memory while plain Men polysaccharide vaccine induces tolerance 37th Interscience Conference on Antimicrobial Agents and Chemotherapy 1997 Toronto Toronto Makela PH Peltola H Polysaccharide vaccines of group A Neisseria meningitides and Haemophylus influenzae type b: a field trial in Finland J lnfect Dis 1977 136 McCornick JB Gusmao HH Nakamura S Antibody response to serogroup A and C meningococcal vaccines in infants born to mothers vaccinated during pregnancy J Clin lnvest 1980 65 Mohammed I Onyemelukwe GC Obineche EN Control of epidemic meningococcal meningitis by mass vaccination: II. Persistence of antibody four years after vaccination J lnfect 1984 9 Noronha CP Struchiner CJ Halloran ME Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study Int J Epidemiol 1995 24 Peltola H Makela PH Kayhty H Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age N Engl J Med 1977 297 Peltola H Safary A Kayhty H Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of o-acetyl-positive group C polysaccharides Pediatrics 1985 76 Peltola H Current status and future possibilities Drugs 1998 55 Perkins B Jonsdottir K Brien H lmmunogenicity of two outer membrane protein-based serogroup B meningococcal vaccines atong young adults in lceland lmmunogenicity of two outer membrane protein-based serogroup B meningococcal vaccines atong young adults in lceland 3th lnterscience Conference on Antimicrobial Agents and Chemotherapy 1994 Oct 4-7 Orlando Fla Reingold AL Broome CV Hightower AW Agespecific differences in duration of clinical protection after vaccinations with meningococcal polysaccharide A vaccine Lancet 1985 2 Shackley FM Heath PT Flamank C lmmunogenicity and reactogenicity of a group C meningococcal conjugase vaccine in British children Clin Infect Dis 1992 23 Sierra GVG Campa HC Varcacel NM Vaccine against group B Neisseria meningitides: protection trail and mass vaccination results in Cuba NIPH Annals 1991 14 Sierra GVG Campa HC García IL Achtman M Marchal C Morelli G Efficacy evaluation of Cuban vaccines VA-MENGOC-BC against disease caused by serogroup B Neisseria meningitides Neisseriae 1990 Neisseriae 1990 1991 ^eBerlin Walter de Gruyter Tai JY Michon PC Fusco PC Combination conjugase vaccine against Neisseria meningitides serogroups A, B, and C Combination conjugase vaccine against Neisseria meningitides serogroups A, B, and C 7th International Congress for lnfectious Diseases 1996 Jun 10-13 Hong Kong Twumasi PA Kumah S Leach A A trial of a group A plus group C meningococcal polysaccharide-protein conjugase vaccine in African lnfants J lnfect Dis 1995 171 Williamson AW Greenwood BM Impairment of the inmune response to vaccination after malaria Lancet 1978 1 Zangwill KM Stout RW Carlone GM Duration of antibody response after meningococcal polysaccharide vaccination in US air force personnel J lnfect Dis 1994 169

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200012 Vacuna de Rotavirus Abdelnour Arturo ,CCSS Hospital Nacional de Niños 04 1999 1999 13 85 85 Rotavirus vaccine for the prevention of Rotavirus gastroenteritis among children Rotavirus vaccine for the prevention of Rotavirus gastroenteritis among children 1999 48 Umesh DP Bresee JS Gentsch JR Glass RI Rotavirus Emerging lnfectious Diseases 1998 4

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200013 Inmunización contra Streptococcus pneumoniae Herrera Marco Luis ,CCSS Hospital Nacional de Niños 04 1999 1999 13 86 88 Alonso De Velasco E Verheul AF Verhoef J Snippe H Streptococcus pneumoniae: virulence factors, pathogenesis and vaccines Microbiol Rev 1995 51 Austrian R Pneumococeus: The first one hundred years Rev. lnfect. Dis. 1981 3 Fedson D Musher D Eskola J Plotkin S. Orestein W. Pneunococcal Vaccines Vaccines Vaccines 1999 3a ed W.B. Saunders Company Hansman D Bullen MM A resistent pneumococcus Lancet. 1967 2 Hedlung J Should pneumococcal infection continue to be classified as a single disease? Lancet. 1997 349 Lalitka MK Pai R Jhon TJ Serotyping of Streptococcus pneumoniae by agglutination assays: A cost-effective technique for developing countries Bull World Health Organ 1996 74 Obaro SK Adegbola RA Banya WA Greenwood BM Carriage of pneumococci after pneumococcal vacunation (letter) Lancet 1996 348 Prevention of Pneumococcal disease: Recomendations of the Advisory Committee on lmmunitation Practices (ACIP) MMWR Rep 1997 46 ^sRR-8 Robbins JB Schneerson R Polysaccharide- protein conjugases: A new generation of vaccines J Infect Dis 1990 161 Scott JAG Hall AJ Dagan R Serogroup-specific epidemiology of Streptococcus pneumoniae: Associations with age, sex and geography in 7,000 episodes of invasive disease Clin lnfect Dis 1996 22 Schweinle JE Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity lnfect Immun 1986 54 Tounamen E Tomasz A Heugstler B Sak O The relative role of bacterial cell wall and capsula in the induction of inflamation in pneumococcal meningitis J lnfec Dis 1985 151 Tuonamen EL Austrian R Masus H Patogenesis of pneumococcal infections N Engl J Med 1995 332

S1409-009019990002 Acta Pediátrica Costarricense Acta pediátr. costarric 1409-0090 Asociación Costarricense de Pediatría S1409-00901999000200014 Vacunas para virus respiratorio sincicial Alfaro-Bourrouet Wilbert ,CCSS Hospital Nacional de Niños San José Costa Rica 04 1999 1999 13 89 90 Anderson L Heilman C Protective and disease-enhancing immune responsos to Respiratory Syncytial Virus J lnfect Dis 1995 171 Bembridge G Garcia-Beato R López J Melero J Taylor G Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following Respiratory Syncytial Virus challenge in BALB/c mice sensitized to the attachment G protein J Immunol 1998 161 Hussell T Georgiou A Sparer T Matthews S Pala P Openshaw P Host genetic determinants of vaccine-induced eosinophilia during Respiratory Syncytial Virus infection J lmmunol 1998 161 Karron R Ambrosino D Respiratory Syncytial Virus vaccines Pediatr lnfect Dis J 1998 17 Kim H Arrobio J Brandt C Wright P Hodes D Chanock R Parrott R Safety and antigenicity of temperatura sensitiva (TS) mutant Respiratory Syncytial Virus (RSV) in infants and children Pediatrics 1973 52 Murphy B Prince G Walsh E Kim H Parrott R Hemming V Rodriguez W Chanock R Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated Respiratory Syncytial Virus vaccine J Clin Microbiol 1986 24 Piedra P Grace S Jewell A Spinelli S Hogerman D Malinoski F Hiatt P Sequential annual administration of purified fusion protein vaccine against Respiratory Syncytial Virus in children with cystic fibrosis Pediatr lnfect Dis J 1998 17 Sáez-Llorens X Castaño E Null D Steichen J Sánchez P Ramilo O Top F Connor E Safety and pharmacokinetics of an intramuscular humanizad monocional antibody to Respiratory Syncytial Virus in premature infants and infants with bronchopulmonary dysplasia Pediatr Infect Dis J 1998 17 Wright P Shinozaki T Fleet W Sell S Thompson J Karzon D Evaluation of a live, attenuated Respiratory Syncytial Virus vaccine in infants J Pediatr 1976 88